Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis in Adults and Children

By DeLeon Jesse  

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis: Data from Six Clinical and Phase I Safety Studies

By Comstock Timothy L.  

Clinical Drug Investigation, Vol. 30, Iss. 10, 2010-10 ,pp. : 675-685

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% in Children and Adolescents with Bacterial Conjunctivitis: A Post Hoc, Subgroup Analysis of Three Randomized, Double-Masked, Parallel-Group, Multicenter Clinical Trials

By Comstock Timothy L.  

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 105-112

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects

By Comstock Timothy L.  

Pediatric Drugs, Vol. 14, Iss. 2, 2012-04 ,pp. : 119-130

Adis International

Access to resources Recommend Favorite

Are there any benefits of Betoptic^® S (betaxolol HCl ophthalmic suspension) over other β-blockers in the treatment of glaucoma?

By Yarangümeli Alper   Kural Gülcan  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1071-1081

Informa Healthcare

Access to resources Recommend Favorite